(Total Views: 480)
Posted On: 11/20/2019 8:05:43 AM
Post# of 64

$HTBX News Article - Heat Biologics Announces Additional Positive Top Line Phase 2 Data of HS-110 plus Nivolumab in Advanced NSCLC Patients https://marketwirenews.com/news-releases/heat...46343.html


My Twitter: WhyteStocks